Get the Stockscreener App
9.09
1.00%
0.09
Cryo Cell International Inc stock is traded at $9.09, with a volume of 24,085.
It is up +1.00% in the last 24 hours and up +50.25% over the past month.
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, kidney, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It stores approximately 500,000 cord blood and cord tissue stem cells worldwide. The company markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.
See More
Previous Close:
$9.00
Open:
$8.87
24h Volume:
24,085
Relative Volume:
1.36
Market Cap:
$72.56M
Revenue:
$31.34M
Net Income/Loss:
$-9.52M
P/E Ratio:
30.30
EPS:
0.3
Net Cash Flow:
$1.28M
1W Performance:
+15.50%
1M Performance:
+50.25%
6M Performance:
+0.55%
1Y Performance:
+87.42%
1-Day Range:
$8.83
$9.10
1-Week Range:
$7.87
$9.10
52-Week Range:
$4.475
$9.498
Cryo Cell International Inc Stock (CCEL) Company Profile
Name
Cryo Cell International Inc
Sector
Industry
Phone
813 749 2100
Address
700 Brooker Creek Boulevard, Suite 1800, Oldsmar
Compare CCEL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| 5.10 | 0 | 0 | 0 | 0 | 0.00 | |
GOODO
Gladstone Commercial Corporation
|
21.49 | 372.90M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.14 | 315.71M | 2.07B | -1.42B | -1.37B | -0.1344 |
|
SHMD
Schmid Group N V
|
2.32 | 99.04M | 0 | 0 | 0 | 0.00 |
|
JUNE
Dhandho Junoon Etf
|
4.72 | 60.87M | 0 | 0 | 0 | 0.00 |
|
DAVEW
Dave Inc
|
0.155 | 0 | 0 | 0 | 0 | 0.00 |
Cryo Cell International Inc Stock (CCEL) Latest News
Umbilical Cord Blood Banking Market Outlook by Examining - openPR
Cell Freezing Media Market Size To Worth USD 333.29 Billion by 2032 | CAGR of 9.15% - GlobeNewswire
Placental Stem Cell Therapy for Neurological Disorders Market Vendor and Technology Assessment Report 2024-... - WhaTech
Cryogenic Insulation Global Market 2024Key Drivers, Growth - openPR
Stem Cell Banking Outsourcing Market Overall Study Report - openPR
Trading (CCEL) With Integrated Risk Controls - Stock Traders Daily
Stem Cell/Cord Blood Banking Market Size, Trend Analysis, Share, Competitive Analysis, And Forecast To 2033 - openPR
Cord Blood Banking Services Market Size, Share Analysis, Trends And Growth Forecast 2024-2033 - WhaTech
Cord Blood Banking Services Market Detailed In New Research - openPR
Stem Cell Banking Market: Stem Cell Banking Market Size Was - openPR
Global Cryogenic Equipment Market 2024 : Trends, Business Growth And Major Driving Factors - openPR
Cord Blood Banking Services Global Market Estimated to Surge at - openPR
(CCEL) Technical Data - Stock Traders Daily
Cell Banking Outsourcing Market Report: Detailed Insights - openPR
Placental Stem Cell Therapy for Neurological Disorders Market Report Scope - InsightAce Analytic
Cryo-Cell reports results of annual stockholder meeting - Investing.com India
Cryo-Cell reports results of annual stockholder meeting By Investing.com - Investing.com UK
Cord Blood Banking Leader Cryo-Cell Declares Initiation of Regular Quarterly Cash Dividend - BioSpace
CRYO-CELL International, Inc. trading resumes - TipRanks
Cryo-Cell announces quarterly dividend for shareholders - Investing.com
Cryo-Cell announces quarterly dividend for shareholders By Investing.com - Investing.com UK
Cord Blood Banking Services Market Trends, Growth, and Demand - openPR
Mesenchymal Stem Cells Market: Cutting-Edge Insights and Comprehensive Analysis - openPR
Stem Cell Storage Service Market 2024Top Regions, Latest - openPR
Major Trend Transforming the Stem Cell Market in 2024: Advancements in Automated Stem Cell Analysis Systems - EIN News
From Lab to Life: Expanding Horizons in Primary Cell Culture - openPR
Cord Blood Banking Services Market Top Key Players, Future Prospects and Forecast by 2031 | Metastat Insight - openPR
Cell Viability Assays Global Market 2024Size, Share, Trends, Outlook To 2033 - openPR
Cell Banking Outsourcing Market Size, Share, Growth & Trends 2024-2033 | Key Players & Outlook - openPR
Cell Banking Outsourcing Market Size, Share and Trends 2024 to 2034 - Precedence Research
Stem Cell Therapy Market Analysis 2024-2031: Growth Driven - openPR
Cell And Gene Therapy Market Size and Growth Forecasts - openPR
GMP Cell Banking Services Market 2024-2031 Market Trends, Size, - openPR
Cell and Tissue Preservation Market Future Business - openPR
Cryogenic Label Printer Market Anticipates a CAGR of 13.18%, Expected to Reach USD 2.5 Billion by 2032 - openPR
3D Cell Culture Market Booms, CAGR of 15.9% To 2030 | Metastat Insight - openPR
Innovations in Cell Isolation: Transforming Healthcare and Research - openPR
Cord Blood Banking Services Market to See Substantial Growth by 2024-2031: Key Drivers and Innovations - EIN News
Stem Cell Banking Market Advancements and Opportunities in Cell Preservation and Research - openPR
Cryo-Cell’s Legal Battle with Duke: Uncertainty and Financial Risks Loom - TipRanks
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2024 Financial Results - BioSpace
(CCEL) Trading Advice - Stock Traders Daily
Cryo-Cell International, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2024 - Marketscreener.com
Economic Sector Performance Dashboards - Yahoo Finance
Cardiac Stem Cell Treatment Market Research: Recent Trends - openPR
Cell Banking Outsourcing Market Size, Share, and Forecast - openPR
Short Interest in Cryo-Cell International, Inc. (NYSEAMERICAN:CCEL) Grows By 186.0% - MarketBeat
A Comprehensive Study Exploring Cell Therapy Market | Key - openPR
Cancer Cell Market Industry Trends and Market Demand Analysis: - openPR
CAR-T Cell Therapy Market Size, Trends, Growth, Opportunities - openPR
Small Cells 5G Network Market Will Exhibit an Impressive Expansion by 2024-2031 - openPR
Cryo Cell International Inc Stock (CCEL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.61%
0.25%
Cap:
|
Volume (24h):